Westchester County, N.Y., funds by Health and Human Services, Department of
Listing $39,416,570.40 in stimulus funds from Health and Human Services, Department of for Westchester
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | $4,143,652 | Trans-NIH Recovery Act Research Support Award Title:-? Novel, Non-antibiotic Therapy for Clostridium difficile-Associated Disease Award Description: Clostridium difficile is a spore-forming bacterium that is the leading cause of hospital acquired diarrhea and is responsible for more deaths per | National Institutes of Health | 9/29/2010 |
| MOUNT VERNON NEIGHBORHOOD HEALTH CENTER, INC. | $2,500,000 | ARRA Health Center Integrated Services Development Initiative[g1] Network Infrastructure and Practice Management Upgrade; Capital Improvement. | Health Resources and Services Administration | 6/25/2009 |
| MOUNT VERNON NEIGHBORHOOD HEALTH CENTER, INC. | $2,500,000 | Capital Improvement Project | Health Resources and Services Administration | 6/25/2009 |
| WESTCHESTER COMMUNITY OPPORTUNITY PROGRAM, INC. | $2,112,406 |
ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: Allocate funds to a network of eligible entities to support employment related services which create and sustain economic growth in keeping with the requirements of the CSBG
This spending item is part of a $86,780,940 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| HUDSON RIVER HEALTHCARE, INC. | $1,994,540 | ARRA Health Center Integrated Services Development Initiative[g1] Hudson River HealthCare received federal CIP funding to: 1. expand dental services in New Paltz, NY 2. expand dental services in Monticello, NY 3. improve organizational efficiency be relocating and consolidating administrative s services in newly ren... Show more | Health Resources and Services Administration | 6/25/2009 |
| WESTCHESTER, COUNTY OF | $1,787,752 |
ARRA Child Care and Development Block Grant ARRA Supplemental Funding for the Child Care and Development Fund (CCDF): Provide child care financial assistance to low-Income working families and fund activities to improve the quality of child care.
This spending item is part of a $96,785,640 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| NEW YORK MEDICAL COLLEGE | $1,743,324 | Trans-NIH Recovery Act Research Support Infantile spasms (IS) represent a devastating epilepsy syndrome of childhood. IS usually develop between 3-12 months with incidence approximately 1 case per 3225 live births. Thus, in the US only there are about 1500 NEW cases of IS, i.e., children who ne | National Institutes of Health | 1/12/2011 |
| WESTCHESTER, COUNTY OF | $1,688,006 |
ARRA Child Care and Development Block Grant ARRA Supplemental Funding for the Child Care and Development Fund (CCDF): Provide child care financial assistance to low-Income working families and fund activities to improve the quality of child care.
This spending item is part of a $96,785,640 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| MOUNT VERNON NEIGHBORHOOD HEALTH CENTER, INC. | $1,686,294 | ARRA Health Center Integrated Services Development Initiative[g1] Increase Demand for Services | Health Resources and Services Administration | 3/27/2009 |
| MOUNT VERNON NEIGHBORHOOD HEALTH CENTER, INC. | $1,686,294 | ARRA Health Center Integrated Services Development Initiative[g1] Increased Demand for Services. | Health Resources and Services Administration | 3/27/2009 |
| OPEN DOOR FAMILY MEDICAL CENTER, INC. | $1,373,255 | ARRA Health Center Integrated Services Development Initiative[g1] Project Title: ARRA - Capital Improvement Program (CIP). This CIP will directly increase capacity to meet demand, improve patient flow and reduce wait times, and allow for faster, more efficient work flow and IT solutions, all of whichch adds up to a higher... Show more | Health Resources and Services Administration | 6/25/2009 |
| HUDSON RIVER HEALTHCARE, INC. | $917,282 | ARRA Health Center Integrated Services Development Initiative[g1] Hudson River Health Care received Increased Demand for Services grant funding to preserve jobs and expand services. Projects include: 1. a new physician and expanded services in Poughkeepsie, NY 2. Retaining 8 employees, including g support for our Earl... Show more | Health Resources and Services Administration | 3/20/2009 |
| WESTCHESTER COMMUNITY OPPORTUNITY PROGRAM, INC. | $841,312 |
ARRA - Head Start ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act. Head Start promotes the school readiness of low-income children through the provision of comprehensive health,
This spending item is part of a $910,800 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| NEW YORK MEDICAL COLLEGE | $795,000 | Trans-NIH Recovery Act Research Support A major goal of cardiac research is to develop the means to repair diseased or damaged hearts with newly generated myocardial tissue. A longstanding paradigm of cardiovascular biology was that the myocardium of the adult mammalian heart is postmitotic. | National Institutes of Health | 6/01/2009 |
| NEW YORK MEDICAL COLLEGE | $765,500 | Trans-NIH Recovery Act Research Support The ability to extract biologically relevant information from the genome of Borrelia burgdorteri, the cause of Lyme disease, continues to be hampered by the lack of genetic tools to identify the biological functions of its many genes of unknown function. | National Institutes of Health | 9/25/2009 |
| INTERNATIONAL BUSINESS MACHINES CORPORATION | $714,898 |
ARRA - Strategic Health IT Advanced Research Projects (SHARP) We propose research that will generate a framework of open source services that can be dynamically configured to transform HER data into standards-conforming, comparable information suitable for large-scale analyses, inferencing, and integegration of dispar... Show more
This spending item is part of a $15,000,000 allocation.
See details
|
Health and Human Services, Department of | 3/19/2010 |
| Yonkers Community Action Program Inc | $714,457 |
ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: Allocate funds to a network of eligible entities to support employment related services which create and sustain economic growth in keeping with the requirements of the CSBG
This spending item is part of a $86,780,940 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| NEW YORK MEDICAL COLLEGE | $659,850 | Trans-NIH Recovery Act Research Support Two hundred million people world wide are affected by thyroid proliferative diseases (TPD), which include goiter, cancer and adenoma. Women are three times more susceptible than men and overall the incidence of thyroid dysfunction occurring in one in eigh | National Institutes of Health | 6/02/2009 |
| NEW YORK MEDICAL COLLEGE | $659,850 | Trans-NIH Recovery Act Research Support Two hundred million people world wide are affected by thyroid proliferative diseases (TPD), which include goiter, cancer and adenoma. Women are three times more susceptible than men and overall the incidence of thyroid dysfunction occurring in one in eigh | National Institutes of Health | 6/02/2009 |
| WESTCHESTER COMMUNITY OPPORTUNITY PROGRAM, INC. | $654,840 | ARRA - Head Start THIS AWARD PROVIDES FUNDS FOR ARRA HEAD START EXPANSION FUNDED TO SERVE 34 CHILDREN. THE PROGRAM PROVIDES COMPREHENSIVE SERVICES FOR LOW-INCOME FAMILIES WITH YOUNG CHILDREN (4 TO 5)TO PROMOTE THE HEALTHY DEVELOPMENT OF CHILDREN AND FAMILIES. WE PROVIDE E | Administration for Children and Families | 9/18/2009 |
| OPEN DOOR FAMILY MEDICAL CENTER, INC. | $625,032 | ARRA Health Center Integrated Services Development Initiative[g1] Project Title: ARRA - Increase Services to Health Centers With the need for affordable primary health care services in our community on a dramatic rise, as evidenced by Open Door's unprecedented growth of uninsured users by the end of f 2008, Open Door is r... Show more | Health Resources and Services Administration | 3/27/2009 |
| WESTCHESTER COMMUNITY COLLEGE | $608,863 |
ARRA - Health Information Technology Professionals in Health Care Tidewater Community College, in collaboration with an active consortium of 22 community colleges, will facilitate the adoption and meaningful use of electronic health records (EHRs) among primary health care providers in the twelve statates of the mid Atlan... Show more
This spending item is part of a $16,267,603 allocation.
See details
|
Health and Human Services, Department of | 4/02/2010 |
| PROGENICS PHARMACEUTICALS, INC. | $580,717 | Trans-NIH Recovery Act Research Support Award Title: HIV-1 Therapy with CCR5 mAb PRO 140 Award Description: PRO 140 is a humanized monoclonal antibody that binds to CCR5, a co-receptor that is the principal molecular portal used by HIV to enter and infect immune system cells. Some strains of | National Institutes of Health | 7/17/2009 |
| NEW YORK MEDICAL COLLEGE | $500,000 | Trans-NIH Recovery Act Research Support The broad, long term objective of this application is to provide investigators at New York Medical College with a FACSAria II high-speed cell sorter to advance studies in important research areas including diabetes, Lyme disease, renal disease, pulmonary | National Institutes of Health | 2/20/2010 |
| NEW YORK MEDICAL COLLEGE | $434,890 | Trans-NIH Recovery Act Research Support We have fully completed the project. We found that levels of neurocan, brevican, aggrecan, phosphacan, and versican were elevated, whereas NG2 expression was reduced in pups and infants with IVH compared to controls. Intracerebroventricular chondroitina | National Institutes of Health | 8/27/2009 |
| PROGENICS PHARMACEUTICALS, INC. | $414,799 | Trans-NIH Recovery Act Research Support Award Title: HIV-1 Therapy with CCR5 mAb PRO 140 Award Description: PRO 140 is a humanized monoclonal antibody that binds to CCR5, a co-receptor that is the principal molecular portal used by HIV to enter and infect immune system cells. Some strains of | National Institutes of Health | 9/27/2010 |
| NEW YORK MEDICAL COLLEGE | $403,767 | Trans-NIH Recovery Act Research Support The overall objective set forth in the currently funded project was to study the role of the heme oxygenase (HO) system in regulating the corneal inflammatory and repair response. This was based on preliminary studies showing that the HO system is highly | National Institutes of Health | 9/23/2009 |
| PHILIPS ELECTRONICS NORTH AMERICA CORPORATION | $403,558 |
Trans-NIH Recovery Act Research Support This application addresses the broad Challenge Area (15) Translational Science and the specific Challenge Topic 15-LM-103: In silico hypothesis testing for biology and medicine. The objective of this project is to determine the feasibility of mathematical
This spending item is part of a $931,419 allocation.
See details
|
National Institutes of Health | 8/12/2010 |
| WINIFRED MASTERSON BURKE MEDICAL RESEARCH INSTITUTE, INC., THE | $401,701 |
Trans-NIH Recovery Act Research Support The present grant aims to achieve the following outcomes across the two-year funding period: 1. to evaluate whether Transcranial Direct Current Stimulation (tDCS) should be delivered sequentially or in parallel to motor training, to enhance motor pattern
This spending item is part of a $467,854 allocation.
See details
|
National Institutes of Health | 5/06/2009 |
| NEW YORK MEDICAL COLLEGE | $349,800 |
Trans-NIH Recovery Act Research Support The purpose of this award to perform research on streptococci and streptococcal diseases in order to better understand the underlying molecular processes, eventually leading to better design of preventative and therapeutic strategies. Group A streptococc
This spending item is part of a $394,800 allocation.
See details
|
National Institutes of Health | 8/01/2009 |
| INTERNATIONAL BUSINESS MACHINES CORPORATION | $307,534 |
Trans-NIH Recovery Act Research Support This project concerns the physiological mechanisms of brain oscillations in the neocortex, a structure vital for perception, thought and memory. Brain oscillations are believed to be important for sensory processing, cognitive states such as attention, an
This spending item is part of a $648,159 allocation.
See details
|
National Institutes of Health | 8/20/2009 |
| CARL ZEISS MICROIMAGING, INC. | $276,115 | Laboratory Equipment | National Institutes of Health | 3/03/2010 |
| WINIFRED MASTERSON BURKE MEDICAL RESEARCH INSTITUTE, INC., THE | $271,827 | Trans-NIH Recovery Act Research Support Stroke induces infiltration of peripheral immune cells into infarct territory and thus exposes blood/serum components to the brain. Because CD36, an inflammatory mediator that contributes to stroke-induced injury, is expressed in peripheral organs/cells, | National Institutes of Health | 8/01/2009 |
| WINIFRED MASTERSON BURKE MEDICAL RESEARCH INSTITUTE, INC, THE | $253,017 | Trans-NIH Recovery Act Research Support The funding requested in this supplement has accelerated the tempo of scientific research in our laboratory, enabled job creation and promoted economic development. Dr. Banerjee has continued with great success the studies that were proposed for this ARRA | National Institutes of Health | 7/17/2009 |
| CARL ZEISS MICROIMAGING, LLC | $227,000 | Laboratory Equipment, microscope system. | National Institutes of Health | 7/12/2010 |
| NEW YORK MEDICAL COLLEGE | $217,929 | Trans-NIH Recovery Act Research Support Lyme disease is the most commonly reported arthropod-borne disease in the United States and the number of reported cases has doubled to over 20,000 per year during the past decade. Lyme disease is caused by the bite of a tick infected with the spirochete, | National Institutes of Health | 9/21/2009 |
| CARL ZEISS MICROIMAGING, INC. | $205,555 | Laboratory Equipment | National Institutes of Health | 12/22/2009 |
| NEW YORK MEDICAL COLLEGE | $173,789 | Trans-NIH Recovery Act Research Support Funding is for a supplement to a grant entitled, G?Determinants of Borrelia burgdorferi Hematogenous DisseminationG?; the long-term objective of the project was elucidation of genes/proteins that mediate B. burgdorferi virulence. Lyme disease, the most co | National Institutes of Health | 9/17/2009 |
| WESTCHESTER, COUNTY OF | $170,401 |
Aging Congregate Nutrition Services for States This Senior Nutrition Program is to provide congregate meals for the elderly. The program was built on the Congregate Meals program authorized by Title III-C-1 of the Older American's Act. However, the Administration on Aging has limited the ARRA fundining... Show more
This spending item is part of a $4,148,718 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| CONSUMERS UNION OF UNITED STATES INC | $165,574 |
The Agency for Healthcare Research and Quality (AHRQ) has awarded a contract to American Institutes for Research. The contract is entitled Community Forum. The contract was awarded in the amount of $9,999,742. The purpose of this contract is to establish
This spending item is part of a $9,999,742 allocation.
See details
|
Agency for Healthcare Research and Quality | 8/11/2010 |
| ORION INTEGRATED BIOSCIENCES, INC | $160,210 |
Trans-NIH Recovery Act Research Support The American Recovery and Reinvestment Act administrative supplement to the Northeast Biodefense Center will support selected research projects for a two-year period. Two projects were chosen based on the level of novelty and their potential to break new
This spending item is part of a $2,286,398 allocation.
See details
|
National Institutes of Health | 9/16/2009 |
| NEW YORK MEDICAL COLLEGE | $141,354 | Trans-NIH Recovery Act Research Support Our recent work shows that the binding of p12 to Pol ?3 causes a change in kpol-exo of nearly an order of magnitude. We can interpret this as a modulation of the conformational change that occurs during switching of the primer terminus from the pol to th | National Institutes of Health | 12/04/2009 |
| FAMILY SERVICES OF WESTCHESTER, INC. | $132,710 | ARRA - Head Start ARRA Cost of Living Adjustment (COLA), and Quality Improvement Funding consistent with the provisions of Section (640)(a)(5) of the Head Start Act | Administration for Children and Families | 6/22/2009 |
| WINIFRED MASTERSON BURKE MEDICAL RESEARCH INSTITUTE, INC, THE | $128,000 | Trans-NIH Recovery Act Research Support This grant allowed Dr. John W. Cave to continue the studies in the Parent Grant while we reapplied to the NIH, specifically The National Institute on Deafness and other Communication Disorders. These funds have permitted the continuation of studies showin | National Institutes of Health | 9/01/2010 |
| MERCY COLLEGE | $122,333 | ARRA - Nurse Faculty Loan Program ARRA - Nurse Faculty Loan Program provides support to students to cover tuition, fees, books and other reasonable education expenses. Eligible students must be enrolled in an eligible Master's program to prepare for a career in nursing. | Health Resources and Services Administration | 8/10/2009 |
| NEW YORK MEDICAL COLLEGE | $100,965 | Trans-NIH Recovery Act Research Support We hypothesize that stress-induced premature senescence (SIPS) is accompanied by subverted autophagy. To obtain direct proof of this hypothesis we propose to perform studies using intravital videomicroscopy of endothelial cells transfected with GFP-LC3 or | National Institutes of Health | 12/15/2009 |
| THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK INC | $100,902 | Trans-NIH Recovery Act Research Support Purchase College, State University of New York is partnering with Dutchess Community College, Rockland Community College and Sullivan County Community College to increase the number of students from underrepresented groups (primarily African Americans an | National Institutes of Health | 3/29/2010 |
| NEW YORK MEDICAL COLLEGE | $100,001 | Trans-NIH Recovery Act Research Support We proposed that as epoxyeicosatrienoic acids (EETs) are vasodilators and natriuretic and can account for the biological actions of adenosine acting on adenosine 2A receptor (A2A R), and that EETs and adenosine play a crucial role in the adaptive respons | National Institutes of Health | 12/08/2009 |
| WESTCHESTER, COUNTY OF | $100,000 |
ARRA - Immunization Section 317 grantees have been allocated ARRA funding to purchase priority vaccines. Funding will support operations infrastructure needed to deliver vaccine and account for those vaccinated. Initiatives to be funded with ARRA grant resources are as fol
This spending item is part of a $3,844,764 allocation.
See details
|
Centers for Disease Control and Prevention | 9/15/2009 |
| NEW YORK MEDICAL COLLEGE | $96,672 | Trans-NIH Recovery Act Research Support We hypothesize that glutamine supplementation in mice chronically treated with non-pressor doses of L-NMMA, a model of early G?asymptomaticG? endothelial dysfunction, may improve mitochondrial function and metabolic profile of endothelial cells, eventuall | National Institutes of Health | 12/18/2009 |
| NEW YORK MEDICAL COLLEGE | $95,400 | Trans-NIH Recovery Act Research Support Long-lasting activity-dependent alterations in the strength of synaptic connections are thought to be essential substrates of memory. Long-term potentiation (LTP) of synaptic transmission has been heavily studied, long-term depression (LTD) of synapse st | National Institutes of Health | 9/24/2009 |
| WINIFRED MASTERSON BURKE MEDICAL RESEARCH INSTITUTE, INC, THE | $91,840 |
Trans-NIH Recovery Act Research Support Stroke is a disease of aging and a leading cause of adult disability in the U.S. In spite of the paucity of treatment strategies in a setting of acute ischemia, increasing evidence suggests that synaptic plasticity and remodeling occur weeks after stroke.
This spending item is part of a $392,929 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
| NEW YORK MEDICAL COLLEGE | $90,714 |
Trans-NIH Recovery Act Research Support Borrelia burgdorferi (Bb), the Lyme disease (LD) spirochete, is maintained in nature via an enzootic cycle which typically involves wild rodents and Ixodes ticks. During the current funding interval, we have used an expanding armamentarium of model system
This spending item is part of a $242,167 allocation.
See details
|
National Institutes of Health | 6/07/2010 |
| WESTCHESTER, COUNTY OF | $83,841 |
Aging Home-Delivered Nutrition Services for States This Senior Nutrition Program is to provide home delivered meals for the elderly. The program was built on the Home Delivered Meals program authorized by Title III-C-2 of the Older American's Act. However, the Administration on Aging has limited ththe ARR... Show more
This spending item is part of a $2,042,446 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| NEW YORK MEDICAL COLLEGE | $79,667 | Trans-NIH Recovery Act Research Support Long term survival of childhood cancers is now more than 70%. The studies of children 4 to 20 years after doxorubicin treatment have found significant cardiac insufficiency. The early effects of doxorubicin may be attributed to altered Ca+2 dynamics, incr | National Institutes of Health | 9/01/2010 |
| NEW YORK MEDICAL COLLEGE | $73,537 | Trans-NIH Recovery Act Research Support T. gondii is an obligate intracellular category B priority pathogen that causes the disease toxoplasmosis and is a model system for other priority B protozoa including Cryptosporidium parvum and Cyclospora caytanensis. Our long-term objective of this gran | National Institutes of Health | 9/21/2009 |
| NEW YORK MEDICAL COLLEGE | $68,850 | Trans-NIH Recovery Act Research Support Evidence from our ongoing behavioral studies in narcoleptic, orexin receptor deficient mice indicate that increases in cholinergic outflow following the loss of orexin signaling contributes to the disregulation of muscle atonia (cataplexy) which occurs in | National Institutes of Health | 9/21/2009 |
| PHILIPS ELECTRONICS NORTH AMERICA CORPORATION | $56,258 |
Trans-NIH Recovery Act Research Support The primary goal of this project is to evaluate the role of FDG PET and its ability to predict early treatment response and drug resistance in advanced epithelial ovarian cancer (AOC). A vast majority of ovarian cancer patients present with advanced stag
This spending item is part of a $698,108 allocation.
See details
|
National Institutes of Health | 5/21/2009 |
| NEW YORK MEDICAL COLLEGE | $54,000 | Trans-NIH Recovery Act Research Support The aim of the proposed project is to determine the role of the ID1 and E2A HLH transcription factors in angiogenesis by examining their effect on mesenchymal cell/pericyte growth, differentiation and production of growth factors. Mesenchymal progenitor ( | National Institutes of Health | 4/06/2010 |
| CARL ZEISS MICROIMAGING, INC. | $51,422 | Laboratory Equipment | National Institutes of Health | 6/02/2010 |
| CARL ZEISS MICROIMAGING, INC. | $49,803 | Laboratory Equipment | National Institutes of Health | 4/05/2010 |
| NEW YORK MEDICAL COLLEGE | $45,999 |
Trans-NIH Recovery Act Research Support This supplemental award supports the Accelerating Clinical Trials of Novel Oncologic Path Ways (ACTNOW) program for Protocol ANBL0931, which is a Phase III Study of Chimeric Antibody 14.18 in High-Risk Neuroblastoma. The primary objective of study ANBL09
This spending item is part of a $1,981,588 allocation.
See details
|
National Institutes of Health | 8/07/2009 |
| NEW YORK MEDICAL COLLEGE | $45,000 |
Trans-NIH Recovery Act Research Support This supplemental award supports the Accelerating Clinical Trials of Novel Oncologic Path Ways (ACTNOW) program for Protocol ANBL0931, which is a Phase III Study of Chimeric Antibody 14.18 in High-Risk Neuroblastoma. The primary objective of study ANBL09
This spending item is part of a $1,981,588 allocation.
See details
|
National Institutes of Health | 8/07/2009 |
| Westchester Community Opportunity Programs Inc | $44,290 |
ARRA - Head Start ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act. Head Start promotes the school readiness of low-income children through the provision of comprehensive health,
This spending item is part of a $910,800 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| WESTCHESTER COUNTY HEALTH CARE CORP | $41,500 |
ARRA - Preventing Healthcare-Associated Infections The major goal of this project is to evaluate surveillance, prevention and control strategies for Clostridium difficle infections in acute care hospitals and develop a long term healthcare-associated infections prevention plan.
This spending item is part of a $1,599,048 allocation.
See details
|
Centers for Disease Control and Prevention | 8/31/2009 |
| MERCY COLLEGE | $38,402 | ARRA - Scholarships for Disadvantaged Students Scholarships to cover tuition fees for disadvantaged students seeking a degree in health professions: physical therapy, occupational therapy, speech pathology or physcian assistant programs. | Health Resources and Services Administration | 6/14/2010 |
| Berlin Productions Inc | $35,000 |
Trans-NIH Recovery Act Research Support This revised R21 research grant application represents a partnership between the YMCA of Greater New York (YNY) and Columbia University. Over 2 years, the planned study will adapt a parent-involvement program for combined use with a previously tested prog
This spending item is part of a $425,198 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| NEW YORK MEDICAL COLLEGE | $34,185 | Trans-NIH Recovery Act Research Support This administrative supplment supports a high school teacher to carry out research during summer 2010 with the goal of identification of novel antibacterial compounds targeting bacterial topoisomerase I. In silico screening will be carried out using newl | National Institutes of Health | 5/24/2010 |
| CARL ZEISS MICROIMAGING, INC. | $28,670 | Laboratory Equipment | National Institutes of Health | 9/15/2009 |
| NEW YORK MEDICAL COLLEGE | $27,943 |
Trans-NIH Recovery Act Research Support Overall Project : Francisella tularensis is considered to be a Category A agent by the NIAID because of its extreme infectivity, ease of dissemination, and substantial capacity to cause illness and death. This Program Project brings together a diverse gro
This spending item is part of a $4,640,929 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
| NEW YORK MEDICAL COLLEGE | $27,943 |
Trans-NIH Recovery Act Research Support Overall Project : Francisella tularensis is considered to be a Category A agent by the NIAID because of its extreme infectivity, ease of dissemination, and substantial capacity to cause illness and death. This Program Project brings together a diverse gro
This spending item is part of a $4,640,929 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
| CARL ZEISS MICROIMAGING, INC. | $26,823 | Laboratory Equipment | National Institutes of Health | 4/05/2010 |
| Union Child Day Care Center Inc | $25,198 |
ARRA - Head Start ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act. Head Start promotes the school readiness of low-income children through the provision of comprehensive health,
This spending item is part of a $910,800 allocation.
See details
|
Administration for Children and Families | 7/01/2009 |
| CARL ZEISS MICROIMAGING, LLC | $22,540 | Laboratory Equipment; microscope | National Institutes of Health | 9/28/2010 |
| NEW YORK MEDICAL COLLEGE | $16,345 | Trans-NIH Recovery Act Research Support The supplement will guide two summer interns to investigate the potential protective functions of QR2 electron donors on differentiated neuronal cells and crystallization of QR2 in complex with substrate analogs. The first project will focus on the effect | National Institutes of Health | 7/21/2009 |
| CARL ZEISS MICROIMAGING, INC. | $14,348 | Laboratory Equipment | National Institutes of Health | 9/04/2009 |
| NEW YORK MEDICAL COLLEGE | $14,094 | Trans-NIH Recovery Act Research Support The award was an administrative supplement to employ a highschool student for two summers to work full time on a project relevant to the parent grant. The goal of the award was to provide research experience to high school students, to liason with seconda | National Institutes of Health | 6/04/2009 |
| NEW YORK MEDICAL COLLEGE | $13,470 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| NEW YORK MEDICAL COLLEGE | $5,230 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| NEW YORK MEDICAL COLLEGE | $732 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |